The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended new measures to reduce the risk of dosing errors with medicines containing methotrexate.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results